{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T17:32:33Z","timestamp":1693243953040},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1097\/inf.0000000000001319","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T23:00:55Z","timestamp":1472684455000},"page":"e378-e383","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children"],"prefix":"10.1097","volume":"35","author":[{"given":"Retsilisitsoe R.","family":"Moholisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schomaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Coovadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Strehlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faeezah","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francoise","family":"Pinillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/FTD.0b013e3181dca14b","article-title":"Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?","volume":"32","author":"Rakhmanina","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/339074","article-title":"The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.","volume":"34","author":"Mannheimer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R3-13-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.qai.0000197071.77482.6e","article-title":"Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.","volume":"41","author":"Liu","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-13-20210202","first-page":"3966","article-title":"De, Bonora S, Garazzino S, et al.","volume":"49","author":"Requena","year":"2005","journal-title":"Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine prim"},{"key":"R5-13-20210202","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa0906626","article-title":"Antiretroviral therapies in women after single-dose nevirapine exposure.","volume":"363","author":"Lockman","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/adc.2009.169375","article-title":"Long-term safety and effectiveness of lopinavir\/ritonavir in antiretroviral-experienced HIV-1-infected children.","volume":"95","author":"Rudin","year":"2010","journal-title":"Arch Dis Child"},{"key":"R7-13-20210202","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.2010.1278","article-title":"Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.","volume":"304","author":"Coovadia","year":"2010","journal-title":"JAMA"},{"key":"R9-13-20210202","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/aid.2006.22.232","article-title":"Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.","volume":"22","author":"Leth","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3851\/IMP2749","article-title":"Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen.","volume":"19","author":"Moholisa","year":"2014","journal-title":"Antivir Ther"},{"key":"R12-13-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(12)70051-8","article-title":"Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial.","volume":"12","author":"Kuhn","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R13-13-20210202","first-page":"1","article-title":"AMELIA II: a program for missing data.","volume":"45","author":"Honaker","year":"2011","journal-title":""},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18+ years.","volume":"91","author":"Rubin","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00401706.1979.10489751","article-title":"Generalized cross-validation as a method for choosing a good ridge parameter.","volume":"21","author":"Golub","year":"1979","journal-title":"Technometrics"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1214\/ss\/1038425655","article-title":"Flexible smoothing with B-splines and penalties.","volume":"11","author":"Eilers","year":"1996","journal-title":"Stat Sci"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.csda.2013.02.017","article-title":"Model selection and model averaging after multiple imputation.","volume":"71","author":"Schomaker","year":"2014","journal-title":"Comput Stat Data Anal"},{"key":"R19-13-20210202","first-page":"382","article-title":"Bayesian model averaging: a tutorial.","volume":"14","author":"Hoeting","year":"1999","journal-title":"Stat Sci"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18 + years.","volume":"91","author":"Rubin","year":"2012","journal-title":"J Am Stat Assoc"},{"key":"R21-13-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00007691-200404000-00006","article-title":"Therapeutic drug monitoring in children with HIV\/AIDS.","volume":"26","author":"Fraaij","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/INF.0000000000000241","article-title":"Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1 infected children and adolescents: an open-label, multiple dose, cross-over study.","volume":"33","author":"Giaquinto","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:12:15Z","timestamp":1620954735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201612000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001319","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}